Avantor Provides Lower Than Expected Guidance
Avantor (AVTR) provided weaker-than-expected guidance for 2026, leading to a decline in its stock price. The company's bioprocessing revenue is expected to remain stagnant compared to peers forecasting growth.
Tickers: $AVTR